Cognetivity Neurosciences Ltd. (CGNSF)
CGNSF Stock Price Chart
Explore Cognetivity Neurosciences Ltd. interactive price chart. Choose custom timeframes to analyze CGNSF price movements and trends.
CGNSF Company Profile
Discover essential business fundamentals and corporate details for Cognetivity Neurosciences Ltd. (CGNSF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
8 Jan 2021
Employees
2.50K
Website
https://www.cognetivity.comCEO
Sina Habibi
Description
Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia; and offers OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.
CGNSF Financial Timeline
Browse a chronological timeline of Cognetivity Neurosciences Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 26 Feb 2025
Earnings released on 29 Jan 2025
Earnings released on 29 Oct 2024
Earnings released on 16 Jul 2024
Earnings released on 3 Apr 2024
Earnings released on 29 Dec 2023
EPS came in at -$0.02 falling short of the estimated -$0.01 by -16.17%, while revenue for the quarter reached $21.18K , missing expectations by -90.64%.
Earnings released on 29 Sept 2023
EPS came in at -$0.02 falling short of the estimated -$0.02 by -9.76%, while revenue for the quarter reached $15.19K , beating expectations by +0.23%.
Earnings released on 29 Jun 2023
EPS came in at -$0.02 falling short of the estimated -$0.01 by -145.12%, while revenue for the quarter reached $3.06K .
Earnings released on 2 Jun 2023
EPS came in at -$0.02 , while revenue for the quarter reached $33.98K .
Earnings released on 16 Dec 2022
EPS came in at -$0.02 falling short of the estimated -$0.01 by -125.89%.
Earnings released on 29 Sept 2022
EPS came in at -$0.02 falling short of the estimated -$0.01 by -100.00%.
Earnings released on 29 Jun 2022
EPS came in at -$0.02 falling short of the estimated -$0.01 by -100.00%.
Earnings released on 3 Jun 2022
EPS came in at -$0.07 falling short of the estimated -$0.01 by -600.00%.
Earnings released on 17 Dec 2021
EPS came in at -$0.08 falling short of the estimated -$0.01 by -700.00%.
Earnings released on 29 Sept 2021
EPS came in at -$0.01 matching the estimated -$0.01.
Earnings released on 29 Jun 2021
EPS came in at -$0.01 matching the estimated -$0.01.
Earnings released on 31 May 2021
EPS came in at -$0.02 falling short of the estimated -$0.01 by -100.00%.
Earnings released on 23 Dec 2020
EPS came in at -$0.00 .
Earnings released on 28 Sept 2020
EPS came in at -$0.01 .
CGNSF Stock Performance
Access detailed CGNSF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.